ArticleFrontiers in immunology2026
Desialylation and sialidase secretion from monocytes and macrophages upon LPS activation.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The cell surface expresses a dense layer of glycans often terminated with sialic acids (Sias), known as sialylation, which represents different cellular statuses. Meanwhile, the removal of Sias from the glycans catalyzed by sialidase (desialylation) is also involved in many biological processes, such as inflammatory responses. Previous studies demonstrated that desialylation is involved in LPS/TLR4 signaling pathway and pro-inflammatory cytokine production. In this report, we systematically profiled desialylation and sialidase activity, expression and secretion from monocytes and macrophages upon LPS activation. Methods: THP-1 monocytes and THP-1 macrophages were activated by LPS (100 ng/mL) for 24 hours. The cellular Sia changes (or desialylation) was quantified by measuring the total Sia level in cell lysates by LC-MS/MS method. The cell surface desialylation was confirmed by detecting the Gal exposure (after desialylation) of the cells by flow cytometry with PNA lectin staining. Total cellular desialylation was confirmed by lectin blot for both THP-1 monocytes and THP-1 macrophages. The sialidase activity in THP-1 monocytes and THP-1 macrophages and their culture media were determined by using the exogenous sialidase substrate 4-MU-Neu5Ac and ganglioside GM3, respectively. Neu1 and Neu3 sialidase levels in THP-1 monocytes and THP-1 were determined by western blot. Neu1 and Neu3 sialidase levels in in the supernatant of THP-1 monocytes and THP-1 macrophages were determined by ELISA. Results: The total Sia level reduced significantly in both THP-1 monocytes and THP-1 macrophages upon LPS activation. Meanwhile, sialidase expression and activity increased significantly in THP-1 monocytes and THP-1 macrophages upon LPS activation. Surprisingly, sialidase activities also significantly increased in the cell culture media of both THP-1 monocytes and THP-1 macrophages, indicating sialidase secretion from THP-1 monocytes and THP-1 macrophages upon LPS activation. In comparison, THP-1 macrophages are highly desialylated than THP-1 monocytes upon LPS activation. Conclusion: LPS activation causes significant desialylation of both THP-1 monocytes and THP-1 macrophages. Desialylation is consistent with enhanced expression and activity of Neu1 and Neu3 sialidase and their secretion from both THP-1 monocytes and THP-1 macrophages upon LPS activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.